Screener
Insulet PODD Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Insulet’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
FAQ
- What is Insulet's cash & equivalents?
- Insulet (PODD) reported cash & equivalents of $534.9M in Q2 2026.
- How has Insulet's cash & equivalents changed year-over-year?
- Insulet's cash & equivalents decreased by 52.3% year-over-year, from $1.12B to $534.9M.
- What is the long-term trend for Insulet's cash & equivalents?
- Over 5 years (2020 to 2025), Insulet's cash & equivalents has grown at a -4.9% compound annual growth rate (CAGR), from $922M to $716.1M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Insulet's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude